# Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer

> **NIH NIH R37** · UNIVERSITY OF CALIFORNIA-IRVINE · 2022 · $83,389

## Abstract

The supplement instructions PA-21-071 state: “At minimum, the Research Strategy section
should be completed and must include a summary or abstract of the funded parent award or
project. Other sections should also be included if they are being changed by the proposed
supplement activities.”
The original Project Summary/Abstract document has not changed as a result of the proposed
supplement activities.

## Key facts

- **NIH application ID:** 10589482
- **Project number:** 3R37CA252081-02S1
- **Recipient organization:** UNIVERSITY OF CALIFORNIA-IRVINE
- **Principal Investigator:** Remi Buisson
- **Activity code:** R37 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $83,389
- **Award type:** 3
- **Project period:** 2021-07-01 → 2026-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10589482

## Citation

> US National Institutes of Health, RePORTER application 10589482, Molecular Mechanisms of APOBEC-Induced Mutagenesis in Cancer (3R37CA252081-02S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10589482. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
